Syngene International Limited
Abstract: Syngene International, one of India’s leading Contract Research Organizations, works with many of the world’s leading biopharmaceutical companies to develop novel therapeutic agents. Over the past 23 years since commencing operations, Syngene has developed a comprehensive suite of services in drug discovery, development and manufacturing. With a team of 3,500 highly skilled employees, we collaborate with a wide variety of 290+ customers ranging from start-up biotech through to leading multinational organizations including 8 of the top 10 global biopharmaceutical companies. Syngene’s state-of-the-art research and manufacturing infrastructure is spread across 1.3 million sq. ft space and includes Chemistry & Biology Laboratory Centers, a cGMP Kilo Lab, commercial manufacturing facility, Bio-manufacturing Facilities, HPAPI manufacturing plant, Animal Research Facilities, Formulation Development Center, Stability Center and clinical research facilities.
Description: Syngene International, one of India’s leading Contract Research Organizations, works with many of the world’s leading biopharmaceutical companies to develop novel therapeutic agents. Over the past 23 years since commencing operations, Syngene has developed a comprehensive suite of services in drug discovery, development and manufacturing. With a team of 3,500 highly skilled employees, we collaborate with a wide variety of 290+ customers ranging from start-up biotech through to leading multinational organizations including 8 of the top 10 global biopharmaceutical companies.
Our collaborations span from simple fee-for-service (FFS) projects through to full-time-equivalent (FTE) enabled assignments and include fully integrated drug discovery and development programs with dedicated infrastructure and teams. We have set up dedicated R&D centers for global organizations including BMS, Amgen, Abbott, Baxter and Herbalife Nutrition.
Our services in discovery, development and manufacturing cover small and large molecules, antibody-drug conjugates and oligonucleotides. These service offerings also support the development of bio-similar and generic molecules.
Syngene’s integrated discovery and development platforms help organizations conduct discovery (from hit to candidate selection), development (including pre-clinical and clinical studies, analytical and bio-analytical evaluation, formulation development and stability studies) and pilot manufacturing (scale-up, pre-clinical and clinical supplies) with a distinctive economic advantage.
We offer comprehensive CMC services for drug substance and drug product from gram scale to commercial supplies. We also have High Potent development and manufacturing capability for intermediates and API’s. We have a track record of identifying leads and advancing the molecules into clinical phases in the shortest possible time.
Syngene’s state-of-the-art research and manufacturing infrastructure is spread across 1.3 million sq. ft space and includes Chemistry & Biology Laboratory Centers, a cGMP Kilo Lab, commercial manufacturing facility, Bio-manufacturing Facilities, HPAPI manufacturing plant, Animal Research Facilities, Formulation Development Center, Stability Center and clinical research facilities.
Our quality systems adhere to stringent global norms such as cGMP (including ICH, FDA), GLP (OECD gu
Alternative resource: [email protected]
Category: Drug Substance
Type: Small Molecules / Biologics
Contact: Ganesh Vaidyanathan ([email protected])